Detalles de la búsqueda
1.
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.
Am J Respir Crit Care Med
; 199(2): 220-231, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30092143
2.
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
Am J Respir Crit Care Med
; 195(9): 1171-1180, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28060545
3.
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.
Vaccine
; 35(12): 1652-1661, 2017 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28216183
4.
Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis.
Vaccine
; 34(21): 2430-2436, 2016 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27026148
5.
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.
EBioMedicine
; 7: 278-86, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27322481
Resultados
1 -
5
de 5
1
Próxima >
>>